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ABSTRACT
Several mechanisms of immunologic tolerance have
been proposed, including deletion, anergy and active
suppression. Deletion and anergy have been reported
based on data from both in vivo and in vitro experi-
ments, but evidence to support the involvement of active
suppression in tolerance has been elusive, principally
because of the difficulty in defining regulatory T (Tr) cells
with immunosuppressive activity. However, data charac-
terizing the function of Tr cells has recently begun to
emerge both from experiments in the field of oral toler-
ance and from others utilizing transgenic (Tg) mice. One
such model which we described uses Tg mice expressing
a foreign physiological soluble antigen, beef insulin (BI),
while another uses T cell receptor (a/b ) Tg mice, whose
T cell receptors (TCR) are specific for ovalbumin (OVA).
Using such models, adoptive transfer of the Tr clones
specific for myelin basic protein (MBP) from orally
tolerant mice into naive mice was shown to protect the
animals from experimental autoimmune encephalo-
myelitis (EAE). Transforming growth factor-beta (TGF-b )
has been shown to be responsible for the immuno-
suppression. Tr clones functioning in self-tolerance have
also been obtained from mice expressing TCR or BI
transgenes. T cell cultures from OVA specific TCR
expressing Tg mice were stimulated in the presence
of interleukin-10 (IL-10) and OVA peptide to produce
Tr clones. The Tr clones secreted IL-10 and TGF-b as
immunosuppressive factors. Tr clones with a different
characteristic have been obtained from BI Tg mice.
Adoptive transfer of the Tr clones into normal mice
suppressed the BI specific antibody response. These
Tr clones have type II Th cytokine profile and produced
TGF-b as an inhibitory cytokine. TGF-b production also
led to functional bystander suppression in the BI Tg
mice. These three different types of Tr clones show
considerable heterogeneity in the cytokine profiles.
Further investigation of Tr cells will be important for our
understanding of autoimmunity and the development of
tactics for the therapy of autoimmune disease.
Key words: active suppression, autoimmunity, inter-
leukin-10, transforming growth factor-beta, transgenic
mice.
INTRODUCTION
Tolerance is one of the distinguishing features of the
immune system, as a consequence of the need to
discriminate self and non-self (foreign) antigens. Break-
down of this ability results in pathological immune
response to self antigens (autoimmunity). An under-
standing of the mechanisms of tolerance induction and
its maintenance is a prerequisite for the development of
therapies for autoimmune disease. These mechanisms
are also clinically relevant in transplantation and tumor
immunology.
Hyperresponsiveness to antigenic stimuli can be induced
both intrathymically (central tolerance) and extrathymi-
cally (peripheral tolerance).1–3 Three main mechanisms to
explain tolerance have been proposed. These are clonal
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deletion,1,4 anergy5,6 and active suppression.7 Clonal dele-
tion theory predicts T cell clones which are autoreactive are
eliminated by apoptosis.8 Anergy of T cells develops fol-
lowing incomplete T cell receptor stimulation, resulting in
abortive activation of signal transduction.10 Anergy5 and
clonal deletion8 have been reported using both in vitro and
in vivo experiments. Clear demonstrations of mechanisms
of active suppression have been elusive until recently due to
the difficulty of obtaining cloned regulatory T (Tr) cells.
Technical advances in establishing transgenic (Tg) mice
have made it possible to establish mice expressing ‘foreign
self antigen’, or T cell receptor (TCR), recognizing defined
antigen.11,12 These Tg mice have allowed detailed investiga-
tions of molecular mechanisms involved in self-tolerance.
As evident from recent reports, active suppression is
involved in self-tolerance in these Tg mice.
Other evidence for the existence of Tr cells with sup-
pressive activity has been obtained in the field of oral
tolerance.13 In general, Tr cells involved in oral (and self)
tolerance demonstrate a cytokine profile of type II Th
cells, although some heterogeneity in the Tr population
has become apparent.
In this review, the molecular mechanisms of active sup-
pression using these Tr cells will be discussed based on
the results of Tr clones.
ORAL TOLERANCE
Prevention of experimental autoimmune
disease
Oral administration of antigen induces systemic hyper-
responsiveness to immune response following immuni-
zation with the same antigen.14 Feeding antigen is a
classical method used to induce tolerance. Wells first
described oral tolerance as a state of abrogation of sys-
temic anaphylaxis caused by immunization of antigen in
guinea-pigs.15 Guinea-pigs immunized with hen egg pro-
teins underwent severe anaphylaxis. This hyperimmune
response to the antigen was prevented by previous
feeding of the same antigen. Systemic hyperresponsive-
ness can be observed following the oral administration of
a wide variety of antigens such as heterologous red cells,
bacteria and viruses.14 Oral tolerance is observed in
both humoral and cellular immune responses. However,
T independent antigens are not able to induce hyper-
responsiveness. Although B cells may be potentially
involved in oral tolerance, this hyperresponsiveness is
determined principally by T cells. Oral feeding of hapten-
carrier conjugates clearly demonstrated that the develop-
ment of oral tolerance was carrier dependent.16,17
Several reports have confirmed infectivity of oral toler-
ance. The state of hyperresponsiveness can be transferred
to naive animal by adoptive transfer of lymphocytes from
antigen-fed animals.18,19 The findings in adoptive transfer
experiments strongly support the hypothesis that Tr cells
with immunosuppressive activity are responsible for oral
tolerance.13 Further characterization of the mechanisms of
active suppression awaits a critical appraisal of the bio-
logical and molecular entity of the suppression.
More recent evidence that oral tolerance could pre-
vent and cure experimental autoimmune disease has
revitalized this field.20–22 Immunization of Lewis rats with
myelin basic protein (MBP) induces experimental auto-
immune encephalomyelitis (EAE), which is considered an
animal model of multiple sclerosis. Oral feeding of the
antigen blocks the onset of EAE.23 Similarly, the feeding
of S-antigen, which causes experimental autoimmune
uveoretinitis (EAU), prevents the disease.24 Thus oral tol-
erance elicited by previous antigen feeding has been
convincingly demonstrated in experimental animals.
These experiments have been extended to humans to
test if a similar protocol could cancel out immune res-
ponse following oral administration of antigen. A potent
immunogenic protein, keyhole limpet hemocyanin (KLH),
was used in experiments on human subjects. The group
fed the antigen demonstrated a significant reduction in
KLH specific T cell proliferation and delayed skin test,
suggesting a protocol of oral feeding could be designed
for the therapy of some types of human autoimmune
disease.25
Mechanism of active suppression in
oral tolerance
An important question is which T cell subsets (CD4+ or
CD8+ T cells) are responsible for active suppression.
Experiments using Lewis rats with MBP have suggested
that adoptive transfer of CD8+ T cells was able to protect
the naive rats from EAE.23 However, further experiments
with mice clearly demonstrated that both CD4+ and
CD8+ T cells possessed suppressive activity.26 Mice defi-
cient in CD4 or CD8 membrane surface molecules were
established by the gene targeting method and used to
study oral tolerance. Oral tolerance was induced in mice
deficient in CD8 gene expression27 but in contrast, CD4
depleted or MHC class II deficient mice failed to develop
oral tolerance.28 These results imply that CD4+ Tr cells
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were indispensable for the induction of active suppres-
sion, although CD8+ Tr cells with suppressive activity can
develop.
Recently, interesting mechanisms of oral tolerance
have been reported. The dose of antigen fed appears to
play an important role in determining the mechanism(s)
of tolerance. Large quantities of antigen induce hyper-
responsiveness mediated by clonal deletion and anergy,
whereas a relatively low dose of antigen favors active
suppression.29,30 The exact molecular events which deter-
mine these differences have yet to be elucidated.
Tr cells generated following feeding of a low dose of
antigen produce factor(s) inhibitory to immune responses.
Transwell cultures of CD8+ T cells indicate that trans-
forming growth factor-beta (TGF-b ) is an inhibitory cytokine
for active suppression.31 Anti-TGF-b antibody inhibited
active suppression by the supernatant of Tr cells. TGF-b is
secreted by a wide variety of cells including NK, macro-
phages, LAK, B cells, CD4+ T cells and CD8+ T cells.
Adoptive transfer of either CD4+ T or CD8+ T cells from
SJL mice fed MBP protected recipient animals from EAE.26
Limiting dilution analysis of T cells from MBP fed mice
revealed an increased frequency of TGF-b , interleukin-4
(IL-4) and interleukin-10 (IL-10) producing T cells, whereas
the frequency of interferon-g (IFN-g ) secreting cells is
decreased in the same mice.26 CD4+ T cells showed the
dominant production of IL-4 and IL-10 over CD8+ T cells.
Further molecular characterization of the mechanisms
of suppression requires cloning of these Tr cells. CD4+
T cells were cloned from bulk cultures derived from
mesenteric lymph nodes.32 Interestingly, TGF-b hi T clones
do not secrete IFN-g or IL-2. Generally speaking, these
clones demonstrate a type II Th cell pattern as judged by
the cytokine production profile, although the amounts of
TGF-b , IL-4 and IL-10 secreted varied considerably from
one clone to another. The production of TGF-b seemed
to be independent of IL-4 or IL-10. Chen et al. proposed
to call the Tr subset with TGF-b hi producers type III
Th cells, since this population has a cytokine profile dif-
ferent from that of typical type II Th cells.32
Three clones were further characterized by this group.
Two clones showed secretion of large amounts of TGF- b .
One clone secretes an intermediate amount of TGF-b but
high amounts of IL-4 and IL-10. The amount of IL-4 pro-
duction varies from low to intermediate to high. The IL-10
production levels of the three clones were intermediate
and high. Adoptive transfer of the three clones protected
recipient mice from EAE. One clone (TGF-b hi, IL-4int and
IL-10int) in particular was further characterized by in vivo
experiments. The injection of neutralizing anti-TGF-b
antibody blocked the EAE protection activity of the clone.
However, the immunosuppressive activity of IL-4 and
IL-10 has not been tested in vivo. TGF-b is a causative
agent for the suppression at least.
SELF TOLERANCE
Tr cells developed in vitro
A large body of reports indicate that cytokines play a criti-
cal role in the development of functionally different T cell
subsets. Differential immune responses can be elicited by
the addition of exogenous cytokines.33 For example,
IL-4 and IL-10 produced by type II Th cells obstruct the
development of type I Th cells and promote the differen-
tiation of type II Th cells,34 whereas IFN-g secreted by type
I Th cells inhibits the differentiation of type II Th cells.35 It is
expected that T cell cultures in the presence of particular
cytokines may promote the differentiation of some pecu-
liar types of T cells.
Both human and mouse T cell cultures were stimulated
in vitro in the presence of cytokines to induce a skewed dif-
ferentiation of T cell.12 Naive CD4+ T cells were obtained
from ovalbumin (OVA) specific ab T cell receptor (TCR)
DO11-10 expressing Tg mice. The T cell cultures were
stimulated with antigen presenting splenic cells and OVA
peptide in the presence of IL-10, IL-4 + IL-10 or IL-4. The
addition of IL-10 or IL-4 + IL-10 prompted the develop-
ment of T cells secreting IL-10hi and IL-5hi. The production
of IL-4 in the cultured cells was minimal. Interestingly, the
level of IFN-g produced was comparable with that of type
0 and type I Th cells. This cytokine production profile is
different from that of the typical type II Th cells which
generally show a cytokine profile of IFN-g lo and IL-4hi.
In contrast to these data, cultures with IL-4 developed
a typical type II Th subset (IL-4hi, IL-5hi, IL-10hi, IL-2hi and
IFN- g hi). Thus, the addition of IL-10 into the CD4+ T cell
cultures generated the development of a unique T cell
subset. Groux et al. proposed to call these T cells Tr1
cells since the T cell subset demonstrated immunosup-
pressive activity as described below.12 Similar Tr1 clones
were also generated from human peripheral blood lym-
phocytes.12 This human Tr1 subset produced a very high
level of IL-10, whereas the secretion level of IL-5, IFN- g
and TGF- b were comparable to those of human type
0 Th cells.
The proliferative response of the Tr1 clones was
increased by the addition of neutralizing anti-IL-10 anti-
body into the cultures. But anti-IL-10 antibody did not
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affect growth of type I Th, type II Th or type 0 Th clones.
Neutralizing anti-TGF-b antibody also increased the pro-
liferative response of the mouse and human Tr1 clones.
Proliferative response of the Tr1 clones was almost com-
pletely restored by the combination of anti-TGF- b and
IL-10 antibodies. The immunosuppressive activity of the
Tr1 clones was tested using naive CD4+ T cells in Trans-
well cultures. The proliferative responses of both human
and mouse CD4+ T cells were inhibited by the Tr1 clones
in transwell cultures. Again the combination of the two
neutralizing antibodies almost completely restored the
growth of CD4+ T cells. These results suggest that both
IL-10 and TGF-b are responsible for the immunosuppres-
sive activity of the Tr1 clones.
These Tr1 clones may suppress the proliferation of
inflammatory type I Th cells in vivo. The function of these
Tr1 clones, anti-inflammatory activity, was tested. IL-10
deficient mice developed inflammatory bowel disease
(IBD).36 Treatment with IL-10 considerably mitigated the
development of IBD induced by the transfer of CD4+
CD45RBhi T cells into SCID mice.37 Adoptive transfer of
the Tr1 clones also significantly inhibited the disease
induced by CD4+ CD45RBhi splenic T cells, though the
anti-inflammatory function of the Tr1 clones was demon-
strated only when the mice were fed the antigen, OVA.
Tr cells developed in a physiological condition:
Transgenic mice expressing beef insulin
We have investigated the mechanisms of self-tolerance to
a soluble physiological antigen, insulin.38,39 To this end we
have established Tg BALB/c mice expressing beef insulin
(BI). A genomic human insulin gene was mutated in vitro to
create a BI gene. Insulin consists of A and B chains con-
nected by two interchain disulfide bonds. Amino acid
residues (Thr8/Ile10) of the A chain of the human insulin
gene were mutated to Ala8/Val10 of BI.40 The expression of
BI was examined by measuring the production of ‘human
C-peptide’, which is cleaved from pro-insulin to become
mature insulin. The transcription of the transgene was regu-
lated in a strict tissue specific manner, such that transgene
expression was detected in the b -islet cells of the pancreas
but not in other tissues, including the thymus. The basal
level of BI was very low (1 x 10–11 to 10–10 mol). A glucose
shock test increased the BI level approximately fourfold.
Thus, BI expression was regulated physiologically.40
The BI Tg mice were tolerant to BI and sheep insulin but
not to pork insulin, as determined by assay for insulin
specific antibody production. T cell receptor repertoire
analysis of the Tg mice clearly demonstrated that the TCR
repertoire was altered from that of the normal BALB/c
mice, which showed restricted TCR repertoire.41 These
results support a hypothesis that T cells expressing TCR
with strong affinities to BI were eliminated in the Tg mice,
suggesting clonal deletion of T cells specific to BI. Further
experiments suggested that the CD4+ T cell population
specific for BI contained anergized T cells to BI as well.40,41
Active suppression in BI Tg mice
We next examined BI Tg mice to test whether a third mech-
anism (active suppression) was operational for tolerance.11
A series of experiments clearly demonstrated that tolerance
was induced and maintained extrathymically. Moreover,
adoptive transfer experiments revealed that the T cell
population could induce suppression of immune response
to BI in normal mice. To elucidate the mechanisms of this
active suppression, CD4+ T cells responding to BI were
cloned from both normal and Tg mice following immuni-
zation with BI. Most of the T clones (10/12) from normal
mice possessed type I Th cytokine profile (IL-2hi, IFN-g hi,
IL-4lo and IL-10lo), whereas most of the T clones (11/12)
derived from the BI Tg mice had a cytokine profile typical of
type II Th cells (IL-2lo, IFN-g lo, IL-4hi and IL-10hi). We exam-
ined the immunosuppressive activity of these type II Th
clones by adoptive transfer experiments. Four T clones
could suppress the antibody response to BI in normal mice.
In these experiments, 2 · 106 of the Tr clones were trans-
ferred. However, even the transfer of 1 · 107 cells of other
type II Th clones lacking suppressive activity did not inhibit
antibody response to BI in normal mice (Fig. 1). Adoptive
transfer of a decreased number of the ‘active’ Tr clones
(2 · 103) failed to suppress the BI specific antibody
response. These results demonstrate that active suppres-
sion is functional in self-tolerance to this soluble physio-
logical antigen. Thus, all three mechanisms (deletion,
anergy and active suppression) are involved in preventing
an autoimmune respose to BI in the BI Tg mice.
We tried to identify immunosuppressive cytokine(s)
involved in the BI specific suppression in transwell cul-
tures.42 The proliferation of a type I Th clone specific for
BI was decreased in the presence of the Tr clones.The four
Tr clones described above secreted TGF-b at four times
the level of the non-suppressive type II Th clones. The
addition of neutralizing anti-TGF-b antibody into the trans-
well cultures restored the proliferation of type I Th clones
(Teng et al. unpubl. data). However, anti-TGF-b antibody
did not show any effect on the proliferation of the Tr clones
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themselves, unlike the Tr1 clones described above. Anti-
bodies neutralizing IL-4 and IL-10 did not block the
suppression of the proliferative response of type I Th
clones, suggesting that these cytokines are not immuno-
suppressive in the BI Tg mice.
BYSTANDER SUPPRESSION
Tr cells induced by oral tolerance were shown to demon-
strate bystander suppression. Tr cells developed by oral
administration of antigen suppress the immune response
to a third party antigen unrelated to the fed antigen when
both the fed antigen and the third party antigen are given
simultaneously in the same mice.43,44 Bystander suppres-
sion is generated by immunosuppressive cytokine(s).
TGF-b secreted by Tr cells in oral tolerance has been
shown to have the bystander suppression function.44
The Tr subset in BI Tg mice showed bystander suppres-
sion activity as well.42 This bystander suppression was
tested in two different assays (Fig. 2). A Tr clone was
adoptively transferred into normal mice and the mice
were immunized intraperitoneally with both BI and OVA.
Bystander suppression was measured by the decrease of
OVA specific antibody response. The antibody response
was decreased by some 40% compared to control mice
immunized with OVA alone. In the second assay, BI Tg
mice were immunized with both BI and OVA and
the decrease in OVA specific antibody response was
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Fig. 1 Beef insulin specific regulatory T clones are able to
suppress antibody response after adoptive transfer into syn-
geneic normal non-transgenic mice. The regulatory T clones
(2 · 106 cells of P24X, P6X, P4X and P3X) and CDC35 (control
type II T-helper clone) were adoptively transferred into normal
BALB/c mice. Two type I T-helper clones were also used as
control. These mice were immunized with beef insulin (j) or
ovalbumin (h) to measure antibody production to the antigens.
N denotes mice without adoptive transfer of T clones. Error bars
indicate SD. OD, optical density.
Fig. 2 Two methods to test bystander suppression of beef
insulin specific regulatory T cells. Method A, normal mice were
adoptively transferred with a regulatory T clone and immunized
with beef insulin and ovalbumin. Method B, beef insulin trans-
genic mice were immunized with beef insulin and ovalbumin.
Antibody response to OVA in these mice was compared with that
of the mice immunized with ovalbumin alone. OVA, ovalbumin;
BI, beef insulin; Tg, transgenic.
Fig. 3 Bystander suppression is a local response. Beef
insulin transgenic mice and normal mice were immunized with
ovalbumin and beef insulin in the same (transgenic co-
immunization, h) or different (transgenic split-immunization, )
site. Serum samples were tested for antibody response to
ovalbumin or beef insulin as indicated. (j), normal mice co-
immunized with both ovalbumin and beef insulin; ( ), normal
mice immunized with beef insulin or ovalbumin alone; ( ) beef
insulin transgenic mice immunized with ovalbumin or beef
insulin alone. The arrows indicate antibody response in co-
immunization and split-immunization. OVA, ovalbumin; BI,
beef insulin; OD, optical density.
measured. Again the OVA specific antibody response
was suppressed by about 40%.
We tested whether TGF- b was responsible for the
bystander suppression. The BI Tg mice immunized with
BI and OVA were treated with anti-TGF- b antibody. We
found that OVA specific antibody response was restored
almost to the level of control mice.
Bystander suppression in self-tolerance could be a
local reaction rather than a systemic one. Split immuni-
zation and co-immunization protocols were performed
to test this idea (Fig. 3). In split immunization, the BI Tg
mice were immunized separately with BI and OVA at dif-
ferent sites (left and right foot pads). Co-immunization
was carried out by immunizing BI and OVA in the same
foot pad. The result was clear. Split immunization failed
to produce bystander suppression. In contrast, BI Tg
mice treated by the co-immunization protocol convin-
cingly demonstrated bystander suppression. Bystander
suppression was found to be a temporary phenomenon
rather than a long-lasting response. Bystander suppres-
sion to OVA specific antibody response in BI Tg mice
was measured as a function of days post-immunization.
Bystander suppression was observed for the period
from day 6–7 to day 13–14 post-immunization. When
we tested bystander suppression at 3 months after BI
and OVA co-immunization, no bystander suppression
for OVA specific antibody responses was detected.
Taken together, these experiments suggest that bystander
suppression is a local and temporary phenomenon in
BI Tg mice.
CONCLUSION
No subject has been more controversial in modern
immunology than active suppression. There is strong evi-
dence for clonal deletion. Neverthless, clones which are
autoreactive are found in the periphery.45 The immune
system should be equipped with a device (a fail-safe
mechanism) to protect itself from catastrophic self-
destruction. It has been hypothesized that active
suppression is a mechanism of peripheral tolerance.
Conclusive evidence supporting this hypothesis has been
elusive for many years, mainly due to the difficulty in
defining cellular entity with suppressive activity.
As described in this review, definitive evidence of the
involvement of Tr cells in active suppression has now
been obtained at the level of T clones. An advanced
knowledge of the functions of cytokines in the immune
system was a contributing factor in the investigation.
These Tr clones share a common characteristic as far
as the growth rate is concerned. The slow proliferation
rate of these clones still remains a significant obstacle to
further research.
The Tr clones show a diverse cytokine profile (Table 1).
Thus, OVA specific Tr1 clones show the production of
IFN-g to levels of typical type I Th. One of the Tr clones
developed in oral tolerance showed low IL-4 secretion.
Tr1 clones have been obtained from in vitro culture in the
presence of IL-10. It is not known whether these Tr1 cells
function under physiological conditions in vivo. IL-10 and
TGF- b function as the immunosuppressive factors in the
Tr1 clones. In a model transplantation system in mice,
where renal and skin graft tolerance can be adoptively
transferred by T cell clones produced from portal vein
pre-immunized mice, Gorczynski et al. reported abolition
of activity in adoptive transfer by anti TGF- b and anti
IL-10 antibodies.46
The BI specific Tr clones secrete TGF- b as an inhibitory
factor. IL-10 does not function in the suppression mecha-
nism of the clones.
Further investigation of the molecular mechanisms
involved in active suppression will make a significant
contribution to our better understanding of autoimmunity
and the development of new therapies for the disease.
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Table 1. Heterogeneity of Tr clones
lo, low; int, intermediate; hi, high.
Regulatory T clone IL-2 IFN-g IL-4 IL-10 TGF-b Inhibitory cytokine References
Myelin basic protein
specific lo lo lo/int/hi int/hi hi TGF-b 32
Ovalbumin IL-10
specific lo int/hi lo hi hi TGF-b 12
Beef insulin
specific lo lo hi hi hi TGF-b 11, 42
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